Summarize the latest evidence-based recommendations for assessing and diagnosing patients with EoE

HAE is a rare genetic disease that results in immunologic attacks that can be life threatening. This program provides HCPs with new clinically relevant data presented at ACAAI 2021 about this rare disease.

Individualize CRSwNP treatment based on patient needs and preferences

Discuss the differences between currently approved and emerging biologic treatment options for CRSwNP using data from clinical trials and other analyses

This activity will review current guidelines and evidence for individualizing treatment for patients with asthma and strategies to improve care in rural and underserved settings.

 Summarize the latest research developments in the treatment of plaque psoriasis

Evaluate the latest data on the efficacy, safety, dosing, and administration of novel TYK2 inhibitors for patients with psoriasis.

Asthma is one of the most common chronic conditions in the pediatric population, and although existing medications can reduce symptoms, management is still suboptimal. The availability of novel biologic therapies for the treatment of asthma requires clinicians to better understand when and in which patients to consider them.